Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Vascular Inflammation in Atherosclerosis (COLPET)
NCT02162303Phase 2Completed
- Sponsor
- Montréal Heart Institute
- Start
- May 2014
- Primary completion
- Jul 2015
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in atherosclerotic vascular disease (ASVD), sponsored by Montréal Heart Institute. Started May 2014; status: completed.
02
Drugs
colchicine
03
Conditions
atherosclerotic vascular disease (ASVD)
Beyond the preview
Go deeper on NCT02162303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02162303.